|Bid||1.320 x 7000|
|Ask||1.330 x 7000|
|Day's Range||1.270 - 1.340|
|52 Week Range||1.130 - 6.790|
|PE Ratio (TTM)||-1.19|
|Earnings Date||Aug 2, 2017 - Aug 7, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||3.00|
Q4 2016 Merrimack Pharmaceuticals Inc Earnings Call
NEW YORK, NY / ACCESSWIRE / June 22, 2017 / The Biotech Industry has continued to outperform the broader markets in 2017. Biotech companies appear to be benefitting from a speedier FDA approval process ...
Disappointing trials from XBiotech, Merrimack Pharmaceuticals, and NewLink Genetics have earned the market's ire. But are their declines overdone?